Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer

NCT01019798 is registered in ClinicalTrials.gov with Taipei Medical University Hospital as lead sponsor.

NCT NCT01019798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01019798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer
Lead sponsor
Taipei Medical University Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2009
Completion date
December 31, 2011
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer